BTAI stock touches 52-week low at $2.53 amid sharp annual decline
BioXcel Therapeutics Inc (NASDAQ:BTAI) stock has plummeted to a 52-week low, reaching a price level of just $2.53. With a market capitalization of just $8 million and EBITDA of -$74 million in the ...
Is British American Tobacco p.l.c. (BTI) the Safest Dividend Stock in the UK?
We recently published a list of 10 Safest Dividend Stocks in the UK. In this article, we are going to take a look at where ...